SPINOCEREBELLAR ATAXIAS

Clinical trials for SPINOCEREBELLAR ATAXIAS explained in plain language.

Never miss a new study

Get alerted when new SPINOCEREBELLAR ATAXIAS trials appear

Sign up with your email to follow new studies for SPINOCEREBELLAR ATAXIAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1

New drug trial aims to slow debilitating genetic movement disorder

Disease control Completed

This study tested whether a drug called troriluzole could help control the symptoms of spinocerebellar ataxia (SCA), a group of rare, inherited disorders that cause worsening problems with coordination and balance. For 8 weeks, 141 adults with SCA received either the drug or a pl…

Matched conditions: SPINOCEREBELLAR ATAXIAS

Phase: PHASE2, PHASE3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control

Last updated Mar 13, 2026 15:06 UTC

SPINOCEREBELLAR ATAXIAS

Get alerted when new SPINOCEREBELLAR ATAXIAS trials appear

New drug trial aims to slow debilitating genetic movement disorder